Reference pricing models are emerging as increasingly popular approaches for lowering drug costs.
To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2018.
To get a pulse on the U.S.
Howard Shaps, MD, senior medical director, WellCare of Kentucky, shares details about the Medicaid insurers’ pilot program designed to fight the opioid epidemic.
Fluctuations in drug pricing and medication shortages are among the reasons for rising drug prices. Learn how you can protect your hospital’s bottom line.
Last year was a banner year for generic drug approvals by the FDA. Find out what’s in store for 2017.
Biosimilars will have a significant impact on cancer treatment, with the potential to drive cost savings, but will patients and providers be accepting?
Drug shortages and manufacturer consolidation are leaving their imprint on the price of some generic drugs.